S&P 500 Futures
(-0.08%) 5 304.25 points
Dow J Futures
(-0.09%) 40 140 points
Nasdaq Futures
(-0.05%) 18 465 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(0.20%) $0.928
USD/NOK
(0.17%) $10.86
USD/GBP
(0.00%) $0.792
USD/RUB
(-0.25%) $92.34

Realtime updates for Cyxone AB (publ) [CYXO.ST]

Exchange: STO Sector: Healthcare Industry: Biotechnology
Last Updated28 Mar 2024 @ 07:41

-1.08% SEK 0.0825

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 07:41):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Cyxone AB (publ), a clinical biotech company, develops disease modifying therapies for rheumatoid arthritis, multiple sclerosis, and treatments for virally induced acute respiratory disorders...

Stats
Today's Volume 412 388
Average Volume 1.54M
Market Cap 8.12M
EPS SEK0 ( 2024-02-23 )
Next earnings date ( SEK0 ) 2024-05-10
Last Dividend SEK0 ( N/A )
Next Dividend SEK0 ( N/A )
P/E -0.200
ATR14 SEK0.00100 (1.21%)

Cyxone AB (publ) Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Cyxone AB (publ) Correlation - Currency/Commodity

The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )

Cyxone AB (publ) Financials

Annual 2023
Revenue: SEK0
Gross Profit: SEK-2.54M (0.00 %)
EPS: SEK-0.220
Q4 2023
Revenue: SEK0
Gross Profit: SEK-634 000 (0.00 %)
EPS: SEK-0.0542
Q3 2023
Revenue: SEK0
Gross Profit: SEK-634 000 (0.00 %)
EPS: SEK-0.0528
Q2 2023
Revenue: SEK-1.43M
Gross Profit: SEK263 000 (-18.40 %)
EPS: SEK-0.0599

Financial Reports:

No articles found.

Cyxone AB (publ)

Cyxone AB (publ), a clinical biotech company, develops disease modifying therapies for rheumatoid arthritis, multiple sclerosis, and treatments for virally induced acute respiratory disorders. Its development portfolio comprises Rabeximod in a clinical Phase II program for rheumatoid arthritis and Covid-19 infections; and T20K, a Phase 1 candidate drug for the treatment of multiple sclerosis. The company was incorporated in 2015 and is based in Malmö, Sweden.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators